Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Phase III
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Phase III
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase III
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Phase III
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Clinical
Phase III
Phase III
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase III
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany Swiss Stock Exchange:RO
Globenewswire News
-
February 26, 2021
Phase III
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 Swiss Stock Exchange:RO
Phase III
Vicore Pharma Holding AB (publ) publishes the year-end report for 2020
Phase III
Tigermed Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization
Phase III
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
Phase III
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium...
Firstwordpharma News
-
January 10, 2021
0
Phase III
Zydus Cadila submits Phase I/II clinical trial data of ZyCoV-D, seeks...
Firstwordpharma News
-
December 25, 2020
0
Phase III
Global Roundup: EU Approves ViiV’s HIV-1 Drug and More
Biospace News
-
December 24, 2020
0
Phase III
Rakuten Medical Enrolls First Patient in the U.S. Clinical Trial for...
Biospace News
-
December 23, 2020
0
Phase III
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in...
Firstwordpharma News
-
October 31, 2020
0
1
2
3
...
41
Page 1 of 41
- Advertisement -
MOST POPULAR
Opiant Pharmaceuticals Announces Development Collaboration with National Center for Advancing Translational...
January 2, 2020
Medexus to Present at the Spring Investor Summit on March 25th...
March 23, 2020
AstraZeneca’s Subsidiary Launches Qtern Tablets for Type 2 Diabetes Treatment in...
February 21, 2020
Inovio shares rally after biotech says human trials of coronavirus vaccine...
March 4, 2020
Load more
HOT NEWS
Deals
Celgene Pays Exscientia $25 Million up Front for 3-Year AI Research...
Others
UK regulator unconditionally clears Roche’s purchase of Spark Therapeutics
Commercial
Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA (Omadacycline) with New ECCMID...
Commercial
Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates...
